skip to Main Content

Welcome

Celebrating Over 80 Years Of Service!

The American Academy of Otolaryngic Allergy (AAOA) represents over 2,700 Board-certified otolaryngologists and health care providers. Otolaryngology, frequently referred to as Ear, Nose, and Throat (ENT), uniquely combines medical and surgical expertise to care for patients with a variety of conditions affecting the ears, nose, and throat, as well as commonly related conditions. AAOA members devote part of their practice to the diagnosis and treatment of allergic disease. The AAOA actively supports its membership through education, research, and advocacy in the care of allergic patients.

"Advance the comprehensive management of allergy and inflammatory disease in Otolaryngology-Head and Neck Surgery through training, education, and advocacy."

ADVOCACY UPDATES

United Healthcare Home Immunotherapy Policy Change

United Healthcare has recently announced a policy change. Effective January 1, 2023, UHC will no longer…

Read more

Medicare 2022 Conversion Factor Update

Thanks to lobbying efforts from the House of Medicine, Congress took action this month. The…

Read more

CY 2022 Physician Fee Schedule Proposed Rule Summary

On July 13, the Centers for Medicare & Medicaid Services (CMS) released the Medicare Physician…

Read more

Changes in MACRA

Macra 101 Image

Before the close of 2017, all physicians must take action to avoid the 4 percent cut that will be assessed in 2019 for not participating in the new Quality Payment Program (QPP) authorized by the Medicare Access and CHIP Reauthorization Act (MACRA).  Read More

CMS Announces Changes in MACRA Implementation Timeline. The Centers for Medicare and Medicaid Services (CMS) announced major changes to the implementation of the Medicare Access and CHIP Re-authorization (MACRA).
Read More

Upcoming Dates

06/01/23: Research Grant Cycle
Learn more

06/26/23: Membership Application Deadline to be eligible for AAOA Member rate for the 2023 Basic Course

07/01/23: Scientific Abstract Submission Deadline
Learn more

12/01/23: Research Grant Cycle
Learn more

04/01/24: Fellow Exam Application Deadline
Learn more

EDUCATION

2023 AAOA Basic Course

Register Now to access over 26 hrs of CME | Continuing Certification through our 2023 Hybrid Basic Course in Allergy & Immunology.  Launching with core pre-work on demand June 1, the live component will build on the basics of adding allergy, including hands-on practica.  Post course, registrants have access to all the content until September 1, 2023. Learn More

RESIDENTS

For information about Resident opportunities, DosedDaily, research grants, and other resources. Learn More

IFAR

Available Now

aaoaf-ifar

IFAR Impact Factor: 2.454

IFAR Featured Content: COVID-19 - Free Access
Endonasal instrumentation and aerosolization risk in the era of COVID‐19: simulation, literature review, and proposed mitigation strategies . Read More

Changes in Managing Practices

Working together with AAOA staff, volunteer leadership and members will enable us to have a positive impact on our members’ practices.

Read More

Live and Online CME

2023 AAOA Advanced Course in Allergy & Immunology - Hybrid
On-Demand Access to over 19 hrs of CME | Continuing Certification until June 1
Learn More and Register

2023 AAOA Basic Course in Allergy & Immunology - Hybrid
June 1 - Pre-Work On-Demand
June 29 – July 1 - Live
September 1 - Access
Hyatt Regency Seattle
Learn More and Register

2023 AAOA Annual Meeting - Hybrid
September 29 – October 1, 2023
Embassy Suites by Hilton Nashville Downtown
Learn More and Register

USP 797 Online Module
Learn More and Register

AAOA Educational Stacks
Next Availability - November 1, 2023

News and Updates

American Elm Shortage

American Elm is dying from Dutch Elm Disease. This may explain the concentrate shortage many practices…

Read more

USP General Chapter Released

After a multi-year effort, the long-awaited revision of Chapter 797 Standards for Sterile Compounding (797) of…

Read more
College Allergy Symptoms Treatment Back to Shcool

PRACTICE RESOURCES

AAOA Practice Resource Tool Kit

The American Academy of Otolaryngic Allergy (AAOA) Practice Resource Tool Kit is intended as a guide to help AAOA members integrate allergy into their otolaryngology practice and to continually improve on this integration as new information, regulations, and resources become available.

Read More

PARTNER RESOURCE CENTER

AAOA has launched a Partner Resource Center to bring you partner resources that can assist your practice and patient care.

Visit the New Center>

PATIENT CORNER

Hidden Costs of Allergy Shots

By Rob Stachler, MD, FAAOA

Choosing between sublingual immunotherapy (SLIT) and subcutaneous immunotherapy (SCIT) can often be a very difficult decision.  We are told that the allergy shots are “covered” by our insurance.  We are often lulled into a false sense of security. We then choose the shot route because we think we are going to pay less

Let me tell you…there are hidden costs of allergy that we could get stuck paying if we are not careful.  First and foremost:  Most insurance companies will charge a co-pay per shot.  These co-pays can be up to $20 a shot (every week for 52 weeks/yr and for up to 3 years:  $20 x 52weeks x 3 years:  $3,120 at the minimum).  Most allergy docs will divide the shot into 2 serums (to not mix certain allergens with others that degrade the proteins over time and make the shot less effective).  This means that you may be paying up to $40 a shot visit if you receive 2 shots per session ($6,240, 52 weeks x $40 x 3 years).  Sublingual immunotherapy is much cheaper at this point, and is 90% as effective, for most allergens.  It is also easier to administer your allergy medication to yourself daily at home.

So, be sure to check with you’re your insurance company and ask for the information “in writing” to ensure that you are not hit with any unexpected allergy fees for services rendered. Each insurance plan can be dramatically different, and each allergy clinic may charge different prices for sublingual allergy therapy. The take home message is to compare the entire cost to each application of immunotherapy before making a final decision.

Back To Top